Joan J Kendig

Title: Joan J Kendig: Innovator in Protein Kinase C Peptides

Introduction

Joan J Kendig is a notable inventor based in Campbell, CA (US). She has made significant contributions to the field of biochemistry, particularly in the development of methods for managing withdrawal from addictive substances. With a total of 5 patents to her name, Kendig's work has the potential to impact the treatment of addiction.

Latest Patents

One of her latest patents involves the use of protein kinase C peptides for managing withdrawal from addictive substances. This method describes the administration of one or more peptides that have specific activity for the ε and/or γ isozyme of protein kinase C (PKC). The peptides can be administered prior to, concurrently with, or subsequent to the administration of the addictive substance. Additionally, the patent includes a kit that contains at least one container with a peptide having isozyme-specific activity for εPKC or γPKC, along with instructions for use.

Career Highlights

Joan J Kendig is affiliated with Leland Stanford Junior University, where she continues her research and development in the field of biochemistry. Her innovative approaches to addiction treatment highlight her commitment to improving health outcomes for individuals struggling with substance use disorders.

Collaborations

Kendig has collaborated with esteemed colleagues such as Daria D Mochly-Rosen and Sarah M Sweitzer. These partnerships have further enriched her research and contributed to the advancement of her patented methods.

Conclusion

Joan J Kendig's work in the development of protein kinase C peptides represents a significant advancement in addiction treatment. Her innovative methods and collaborations underscore her dedication to improving health outcomes in this critical area.